<DOC>
	<DOCNO>NCT00190684</DOCNO>
	<brief_summary>To learn safety side effect atomoxetine give child adolescents 5 year ( long-term ) learn whether atomoxetine help child adolescents attention-deficit/hyperactivity disorder ( ADHD ) take drug 5 year ( long-term ) . Study participant atomoxetine naive , atomoxetine experience whose therapy interrupt , atomoxetine experience know stable dose .</brief_summary>
	<brief_title>Long-Term , Open Label Atomoxetine Study</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Must least 6 year old less 18 year old enrol first atomoxetine study Must meet study criterion ADHD Must willing blood drawn complete test require study allergic 1 kind medicine multiple bad reaction drug take certain medicine could interact atomoxetine plan move far away doctor participate study next 5 year current past history following : alcohol drug abuse within past 3 month , bipolar I II disorder , high blood pressure , organic brain disease seizure , psychosis , disorder condition diagnose doctor might make unsuitable participate study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>